Clinical Trials in Oncology and Defining Benefit

被引：0
|
作者：
Sorscher, Steven [1 ]
机构：
[1] Wake Forest Sch Med, Winston Salem, NC 27101 USA
来源：
ONCOLOGIST | 2018年 / 23卷 / 01期
关键词：
D O I：
10.1634/theoncologist.2017-0476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：135 / 135
页数：1
相关论文
共 50 条
  • [1] Clinical Trials in Oncology and Defining Benefit Reply
    Goldberg, Richard M.
    ONCOLOGIST, 2018, 23 (01): : 136 - 136
  • [2] Defining and describing benefit appropriately in clinical trials
    King, NMP
    JOURNAL OF LAW MEDICINE & ETHICS, 2000, 28 (04): : 332 - 343
  • [3] Biased by design? Clinical trials and patient benefit in oncology
    Pantziarka, Pan
    Verbaanderd, Ciska
    Meheus, Lydie
    FUTURE ONCOLOGY, 2020, 16 (03) : 4419 - 4423
  • [4] Randomized clinical trials in oncology stopped early for benefit (RCTSEB).
    Segota, E.
    Soares, H. P.
    Djulbegovic, B.
    Kumar, A.
    Bassler, D.
    Guyatt, G. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 310S - 310S
  • [5] Evidence synthesis analysis with prioritized benefit outcomes in oncology clinical trials
    Cui, Ying
    Dong, Gaohong
    Kuan, Pei Fen
    Huang, Bo
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023, 33 (03) : 272 - 288
  • [6] On the road to new drugs in clinical oncology: benefit of phase 2 trials
    Hochster, Howard S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2025,
  • [7] Challenges for clinical trials in oncology within the scope of early benefit assessment of drugs
    Lange, Stefan
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2015, 109 (06): : 417 - 430
  • [8] Further evidence of clinical benefit associated with participation in phase I oncology trials
    M Markman
    British Journal of Cancer, 2008, 98 : 1021 - 1022
  • [9] Further evidence of clinical benefit associated with participation in phase I oncology trials
    Markman, M.
    BRITISH JOURNAL OF CANCER, 2008, 98 (06) : 1021 - 1022
  • [10] Clinical trials in oncology
    Matos, Erika
    ONKOLOGIJA, 2018, 22 (01) : 38 - 41
12345